Global Molecular Diagnostics Market Size was Valued at 5,962 Million US$ in 2016 and is Expected to Reach 10,557 Million US$ with a CAGR of 9.1% by 2023 – Valuates Reports™
It is expected that technological advances in molecular diagnostics will drive the market dramatically as they allow for greater precision, portability and cost-effectiveness. The launch of MinION, a compact and inexpensive sequencer for users in point-of-care facilities and small peripheral laboratories by Nanopore Technologies, is expected to fuel market growth.
Get Free Sample @ https://reports.valuates.com/request/sample/ALLI-Manu-4H2/molecular_diagnostics_market
Trends Influencing The Molecular Diagnostics Market Share
- Prevalence of infectious ailments and various types of cancer
- Increase in awareness of personalized medication
- Growth in the biomarker identification
- Advancement in molecular diagnostics
View Full Report @ https://reports.valuates.com/market-reports/ALLI-Manu-4H2/molecular-diagnostics-market
Region Wise Analysis Of Molecular Diagnostics Market Share
- In 2016, the North American molecular diagnostics market accounted for the largest market share due to factors such as growing ageing populations, increased numbers of infectious and chronic diseases, and increased awareness of personalized medicine.
- Because of the well-penetrated healthcare system and supportive regulatory policies, the European molecular diagnostics sector is the second-highest revenue generator.
Asia-Pacific is expected to show the highest growth in the global molecular diagnostics market from 2017 to 2023, with an estimated CAGR of 10.1% due to improvements in health care facilities to treat the growing population of patients with infectious diseases.
Key Benefits for Stakeholders
- The study provides an in-depth analysis of the global molecular diagnostics market and current trends and future estimations to elucidate the imminent investment pockets.
- The report provides a quantitative analysis of the industry from 2016 to 2023 to enable the stakeholders to capitalize on the prevailing market opportunities.
- Extensive analysis of the market based on type, technology, application, and end user elucidate various trends and prevailing opportunities across segments.
- Key market players operating in the market are profiled to determine the competitive outlook of the market by studying the different products of the companies and their developments.
- The key players profiled in the report include
Abbott Laboratories, Inc. ,BioMrieux SA , Becton, Dickinson and Company, Cepheid (subsidiary of Danaher Corporation), Grifols,Hologic Corporation , Novartis AG, Qiagen N.V.,Siemens Healthcare GmbH , andRoche Diagnostics . - List of the other players (not included in the report) in the value chain includes
Bayer Healthcare , Bio-Rad Laboratories, Johnson & Johnson,Dalko Diagnostics , and Sysmex Corporation.
Top Investment Pockets
The global molecular diagnostics market is segmented by application into infectious diseases, oncology, genetic testing, blood screening, and others (microbiology, neurological diseases, and cardiovascular diseases).
Infectious diseases projected the highest revenue in 2016, with a CAGR of 9.3% for the forecast period of 2017-2023, owing to an increase in the number of patients suffering from different viral and bacterial infections, such as Human Immunodeficiency Virus (HIV), Hepatitis C virus(HCV), Human Papillomavirus(HPV), Chlamydia trachomatis/ Neisseria gonorrhoeae (CT/NG), and others. Along with the improving healthcare facilities treating these diseases in the emerging nations.
Molecular Diagnostics Market Key Segments
By Product
- Instruments
- Reagents
- Software & Services
By Technology
- Polymerase Chain Reactions (PCR)
- Hybridization
- DNA Sequencing
- Microarray
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Others (Electrophoresis, Mass spectroscopy, and Flow cytometry)
Inquire for Discount @ https://reports.valuates.com/request/discount/ALLI-Manu-4H2/molecular-diagnostics
By Application
- Infectious Diseases
- Oncology
- Genetic Testing
- Blood Screening
- Others (Microbiology, Neurological Diseases, and Cardiovascular Diseases)
By End Users
- Hospitals
- Laboratories
- Others (Blood Banks, Home Health Agencies, and
Nursing Homes )
By Geography
North America U.S. Canada Mexico Europe Germany France UK Italy Spain - Rest of
Europe Asia-Pacific Japan China India - Rest of
Asia-Pacific - LAMEA
Latin America Middle East Africa
Buy Report @ https://reports.valuates.com/api/directpaytoken?rcode=ALLI-Manu-4H2
View Similar Reports :
Global Veterinary Molecular Diagnostics Market : https://reports.valuates.com/market-reports/PROF-Auto-33T111/global-veterinary-molecular-diagnostics-market
Global Molecular Diagnostics Systems Market :
About Us:
Our aim is to collate unparalleled Market insights and notify our customers as and when it happens. Valuates is curating premium Market Research Reports from the leading publishers around the globe. We will help you map your information needs to our report repository of Market research reports and guide you through your purchasing decision. We are based out of
Contact Us:
Valuates Reports
[email protected]
For
For IST Call +91-8040957137
Website: https://reports.valuates.com
View original content:SOURCE Valuates Reports
Nearly 50% Of Boomers Don’t Know When To Add Fixed Income Investments: Study
Sapiens Expands Its Partnership Ecosystem With Lightico to Enhance Digital Customer Interactions for the Insurance Market
Advisor News
- Your client’s $3 million portfolio doesn’t tell you their insurance needs
- How life insurance can provide liquidity for wealthy families
- Retirement providers turn to digital engagement to retain assets
- Looking out for clients with diminished mental capacity
- House panel advances CLEAR Forms Act backed by IRI
More Advisor NewsAnnuity News
- What lower interest rates mean to annuity payouts
- AM Best downgrades A-Cap insurers amid financial and regulatory troubles
- Lawsuit claims Delaware Life hid billions in insurer-linked investments
- AM Best to Deliver Presentation at 2026 ACLI Annual Conference
- Global Atlantic Announces Launch of ForeLifetime Income, a New Fixed Index Annuity
More Annuity NewsHealth/Employee Benefits News
Life Insurance News